Use of an isogenic Escherichia coli panel to design tests for discrimination of β-lactamase functional groups of Enterobacteriaceae

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 3, 1999, Pages 630-633

  Ehrhardt, Anton F ^a   Sanders, Christine C ^a   Moland, Ellen S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFOTETAN; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID;

ARTICLE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032979796     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.3.630     Document Type: Article

References (26)

1. Alksne, L. E., and B. A. Rasmussen. 1997. Expression of the AsbA1, OXA-12, and AsbM1 β-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon, J. Bacteriol. 179:2006-2013.
2. Bradford, P. A., N. V. Jacobus, N. Bhachech, and K. Bush. 1996. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 40:260-262.
3. Bradford, P. A., and C. C. Sanders. 1995. Development of test panel of β-lactamases expressed in a common Escherichia coli host background for evaluation of new β-lactam antibiotics. Antimicrob. Agents Chemother. 39: 308-313.
4. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
5. Bush, K. 1989. Characterization of β-lactamases. Antimicrob. Agents Chemother. 33:259-263.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Cormican, M. G., S. A. Marshall, and R. N. Jones. 1996. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen. J. Clin. Microbiol. 34:1880-1884.
8. Ehrhardt, A. F., C. C. Sanders, and E. S. Moland. 1997. Use of an isogenic Escherichia coli panel in designing tests for β-lactamase detection, abstr. D-16, p. 86. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Gonzalez Leiza, M., J. C. Perez Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
10. Katsanis, G. P., J. Spargo, M. J. Ferraro, L. Sutton, and G. A. Jacoby. 1994. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum β-lactamases. J. Clin. Microbiol. 32:691-696.
11. Medeiros, A. A., M. Cohenford, and G. A. Jacoby. 1985. Five novel plasmid-determined β-lactamases. Antimicrob. Agents Chemother. 27:715-719.
12. Mugnier, P., P. Dubrous, I. Casin, G. Arlet, and E. Collatz. 1996. A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:2488-2493.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969.
15. Nüesch-Inderbinen, M. T., H. Hächler, and F. H. Kayser. 1996. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur. J. Clin. Microbial. Infect. Dis. 15:398-402.
16. Pangon, B., C. Bizet, F. Pichon, A. Philippon, B. Regnier, A. Bure, and L. Gutmann. 1989. In vivo selection of a cephamycin resistant porin mutant of a CTX-1 β-lactamase producing strain of Klebsiella pneumonia. J. Infect. Dis. 159:1005-1006.
17. Pitout, J. D. D., E. S. Moland, and C. C. Sanders. 1996. Changes in porin expression associated with the stepwise increase in resistance to cefoxitin in Klebsiella pneumoniae involved in nosocomial infections, abstr. C39, p. 41. In Abstracts of the 36th Interscienee Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Sambrook, J., E. F. Fritsch, and T. Maniatus. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, N.Y.
19. Sanders, C. C., A. L. Barry, J. A. Washington, C. Shubert, E. S. Moland, M. M. Traczewski, C. Knapp, and R. Mulder. 1996. Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitck ESBL test. J. Clin. Microbiol. 34:2997-3001.
20. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
21. Thomson, K. S., E. S. Moland, and C. C. Sanders. 1997. Use of microdilution panels with and without β-lactamase inhibitors as a specific test for β-lactamase production (βL+) among E. coli and Klebsiella, abstr. D-17, p. 86. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Thomson, K. S., A. M. Prevan, and C. C. Sanders. 1996. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: emerging problems for new β-lactam antibiotics, p. 151-163. In J. S. Remington and M. N. Swartz (ed.). Current clinical topics in infectious diseases, vol. 16. Blackwell Science, Inc., Cambridge, Mass.
23. Thomson, K. S., and C. C. Sanders. 1997. A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM-and SHV-derived extended-spectrum β-lactamases. Clin. Microbiol. Infect. 3:549-554.
24. LAT-1) found in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:2207-2209.
25. Vercauteren, E., P. Descheemaeker, M. Ieven, C. C. Sanders, and H. Goossens. 1997. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Microbiol. 35:2191-2197.
26. Yang, Y., N. Bhachech, P. A. Bradford, B. D. Jett, D. F. Sahm, and K. Bush. 1996. Ceftazidime-resistant Klebsiella pneumoniae and E. coli isolates producing TEM-10 and TEM-43 β-lactamases from St. Louis, abstr. C25, p. 38. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.